Steering Committee of the Renal Lifecycle trial investigating the reno- and cardioprotective efficacy of the SGLT-2 inhibitors dapagliflozine in patients with severe CKD (Externe Organisatie)

Activiteit: Membership › Professional

Periode2022 → …
Gehouden op Steering Committee of the Renal Lifecycle trial investigating the reno- and cardioprotective efficacy of the SGLT-2 inhibitors dapagliflozine in patients with severe CKD
Mate van erkenningInternational